Evidence map›Paper›PMID 22324021›Full record

ArticleHIV sequence compendium2001

A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Robert W Shafer, Kathryn Dupnik, Mark A Winters, Susan H Eshleman

Abstract read
In one paragraph

Article in HIV sequence compendium, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Drug Resistance-Associated Mutations in Antiretroviral Treatment-Experienced Patients in Kuwait.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2018
    Article
  9. Assessment of HIV molecular surveillance capacity in the European Union, 2016.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2017
    Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. HIV-1 antiretroviral drug therapy.Cold Spring Harbor perspectives in medicine · 2012
    Review
  15. Retrospective analysis of the HIV-1 reverse transcriptase inhibitors' resistance in Silesia, Poland.Medical science monitor : international medical journal of experimental and clinical research · 2011
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Reverse transcriptase and protease sequence evolution in two HIV-1-infected couples.Journal of acquired immune deficiency syndromes (1999) · 2002
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Robert W ShaferDivision of Infectious Diseases, Stanford University, Stanford, CA 94305.
Kathryn Dupnik
Mark A Winters
Susan H Eshleman

Funding

Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor)R25TW009337 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HEIMBURGER, DOUGLAS CORBETT, VERMUND, STEN H. · 2012 to 2016
$6.3M
IDENTIFICATION OF MULTIDRUG RESISTANT HIV1 ISOLATESR01AI046148 · NIAID · STANFORD UNIVERSITY · PI SHAFER, ROBERT WILLIAM · 1999 to 2008
$2.4M
FIC NIH HHS R25 TW009337NIAID NIH HHS R01 AI046148
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID22324021
PMCPMC3274565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.